Reflection Asset Management’s West Pharmaceutical WST Stock Holding History

Reflection Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$19K	Buy	+69	New	+$18.9K	0.01%	394

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Reflection Asset Management's WST Position: Q4 2025 in Review

Reflection Asset Management opened a new position in West Pharmaceutical (WST) in Q4 2025: 69 shares worth $19K. The stake represents 0.01% of the portfolio and ranks #394 among its holdings.

804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

Reflection Asset Management held 69 shares of West Pharmaceutical worth $19K as of Q4 2025.
West Pharmaceutical was a new Reflection Asset Management position in Q4 2025.
West Pharmaceutical made up 0.01% of Reflection Asset Management's portfolio in Q4 2025, its #394 holding.
804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.